22 November

Licensing of health technologies: New Report

17 June

WTO institutionally unfit for the purpose of delivering sustainable solutions

9 May

Introducing the TRIPS Flexibilities Navigator

16 March

HAI Statement on Tentative Agreement on TRIPS and COVID-19

8 June

Getting Hack to Reality

19 April

A Pandemic Response Lacking Moral Leadership

23 March

MPs and MEPs Call for TRIPS Waiver

22 March

Challenging the IP Protection Framework

24 February

Over 100 MEPs call for a TRIPS Waiver

24 November

HAI’s Great Health Hack Delivers Great Ideas for Access to Meds

6 October

Europe Faces a Critical Time of Key Medicine Shortages Amidst a Pandemic

28 April

EU Must Not Miss its Chance on WHO Technology Pool

24 April

TRIPS-flexibilities in Health Crises and Beyond

25 September

A Momentous Week for Access to Medicines

31 October

Staff Spotlight: Jaume Vidal

2 October

Medicijnen: de link met de maatschappij

7 February

Open Science for Health: Shaping the New Framework Programme

14 December

EU-Mercosur Trade Agreement: A bad deal for transparency, policy coherence and access to medicines

27 November

New Dutch Government Must Ensure Transparency to Control Medicine Prices

16 October

Staff Spotlight: Tim Reed

27 July

Next Gen Advocates Excel at HAI/HP4L Summer School on Access to Medicines

23 May

‘Achieiving Affordable Access to Health Technologies’ Side Event at WHA69

28 May

Successful week of advocacy for HAI delegation at 68th World Health Assembly

4 February

The EU-US Trade Deal Could Leave Europeans Sick

16 September

Democracy violation: European Commission rejects citizens’ initiative to stop TTIP and CETA

7 April

Governments must ensure Big Pharma’s expansion in Africa doesn’t impede generics supply

31 January

Bayer CEO's callous comments highlight failure of current biomedical innovation model

2 September

Report exposes how Big Pharma has hijacked EU-India trade deal

22 April

Generic prescribing policies 1 – ABPI 0